Total Payments
$4,134
2024 Payments
$293.89
Companies
27
Transactions
195
Medicare Patients
7,153
Medicare Billing
$660,107
Payment Breakdown by Category
Food & Beverage$4,134 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,134 | 195 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $687.78 | 18 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $628.12 | 63 | $0 (2022) |
| Amgen Inc. | $397.89 | 19 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $269.90 | 14 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $204.20 | 12 | $0 (2022) |
| Edwards Lifesciences Corporation | $199.36 | 2 | $0 (2023) |
| Esperion Therapeutics, Inc. | $190.53 | 2 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $168.62 | 11 | $0 (2019) |
| Medtronic, Inc. | $157.42 | 3 | $0 (2024) |
| BIOTRONIK INC. | $145.77 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $293.89 | 4 | Abbott Laboratories ($215.68) |
| 2023 | $590.50 | 6 | Edwards Lifesciences Corporation ($155.10) |
| 2022 | $239.62 | 8 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($62.44) |
| 2021 | $589.94 | 13 | Abbott Laboratories ($286.58) |
| 2020 | $162.18 | 10 | Bardy Diagnostics, Inc. ($50.00) |
| 2019 | $534.88 | 41 | Novartis Pharmaceuticals Corporation ($153.55) |
| 2018 | $1,144 | 69 | Novartis Pharmaceuticals Corporation ($238.19) |
| 2017 | $579.25 | 44 | Novartis Pharmaceuticals Corporation ($150.88) |
All Payment Transactions
195 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Abbott Laboratories | 2ND GEN CENTRIMAG PRIMARY CONSOLE (Device) | Food and Beverage | In-kind items and services | $133.21 | General |
| Category: Heart Failure | ||||||
| 12/17/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $31.04 | General |
| Category: Pacemakers | ||||||
| 10/18/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $47.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/08/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $82.47 | General |
| Category: Vascular | ||||||
| 12/14/2023 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $40.46 | General |
| Category: Pacemakers | ||||||
| 09/28/2023 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $85.92 | General |
| Category: EndoVenous Therapies | ||||||
| 09/06/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $110.31 | General |
| Category: Cardiovascular | ||||||
| 05/11/2023 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $155.10 | General |
| Category: Transcatheter Heart Valves | ||||||
| 02/08/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $120.89 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/31/2023 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $77.82 | General |
| Category: Cardiac Rhythm Management | ||||||
| 09/29/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/13/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $29.77 | General |
| Category: Cardiology | ||||||
| 08/22/2022 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $44.26 | General |
| Category: Transcatheter Heart Valves | ||||||
| 07/28/2022 | Chiesi USA, Inc. | KENGREAL (Drug), CLEVIPREX | Food and Beverage | Cash or cash equivalent | $17.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/27/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/13/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/05/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/05/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $62.44 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/29/2021 | Abbott Laboratories | Merlin Connectivity and Remote (Device) | Food and Beverage | In-kind items and services | $8.94 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/29/2021 | Abbott Laboratories | Confirm Rx (Device) | Food and Beverage | In-kind items and services | $6.10 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/29/2021 | Abbott Laboratories | Confirm Rx (Device) | Food and Beverage | In-kind items and services | $6.10 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/29/2021 | Abbott Laboratories | Merlin Connectivity and Remote (Device) | Food and Beverage | In-kind items and services | $1.97 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/09/2021 | Abbott Laboratories | Quadra Assura CRT Defibrillator (Device) | Food and Beverage | In-kind items and services | $82.69 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/09/2021 | Abbott Laboratories | Merlin Connectivity and Remote (Device) | Food and Beverage | In-kind items and services | $4.55 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/06/2021 | Abbott Laboratories | Assurity Pacemaker (Device) | Food and Beverage | In-kind items and services | $66.01 | General |
| Category: Cardiac Rhythm Management | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,956 | 2,545 | $878,697 | $185,821 |
| 2022 | 14 | 2,236 | 2,838 | $803,696 | $190,709 |
| 2021 | 16 | 2,360 | 3,102 | $894,244 | $232,332 |
| 2020 | 8 | 601 | 838 | $133,583 | $51,245 |
Total Patients
7,153
Total Services
9,323
Medicare Billing
$660,107
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 517 | 1,042 | $392,592 | $96,232 | 24.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 279 | 288 | $274,974 | $41,566 | 15.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 355 | 357 | $86,394 | $19,979 | 23.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 113 | 113 | $58,195 | $14,005 | 24.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 21 | 21 | $14,301 | $3,813 | 26.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 25 | $13,275 | $3,499 | 26.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 284 | 295 | $20,650 | $2,484 | 12.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 298 | 334 | $9,018 | $2,161 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 24 | $6,176 | $1,344 | 21.8% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 14 | 14 | $1,190 | $296.24 | 24.9% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 13 | 13 | $1,001 | $249.47 | 24.9% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 19 | 19 | $931.00 | $192.78 | 20.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 528 | 682 | $219,166 | $55,218 | 25.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 134 | 134 | $146,822 | $37,599 | 25.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 410 | 416 | $97,992 | $23,074 | 23.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 155 | 158 | $134,924 | $23,045 | 17.1% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 94 | 376 | $33,088 | $17,922 | 54.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 160 | 160 | $65,783 | $17,044 | 25.9% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2022 | 119 | 235 | $53,815 | $6,649 | 12.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 271 | 272 | $16,556 | $2,536 | 15.3% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2022 | 109 | 109 | $11,772 | $2,170 | 18.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 36 | $7,556 | $1,879 | 24.9% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2022 | 109 | 109 | $6,649 | $1,814 | 27.3% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 24 | 24 | $5,790 | $1,230 | 21.2% |
| 85610 | Blood test, clotting time | Office | 2022 | 39 | 75 | $1,275 | $321.67 | 25.2% |
About Dr. Deepak Khosla, MD
Dr. Deepak Khosla, MD is a Cardiovascular Disease healthcare provider based in Redding, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1679574701.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deepak Khosla, MD has received a total of $4,134 in payments from pharmaceutical and medical device companies, with $293.89 received in 2024. These payments were reported across 195 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($4,134).
As a Medicare-enrolled provider, Khosla has provided services to 7,153 Medicare beneficiaries, totaling 9,323 services with total Medicare billing of $660,107. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Redding, CA
- Active Since 08/10/2005
- Last Updated 01/11/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1679574701
Products in Payments
- ENTRESTO (Drug) $606.41
- ELIQUIS (Drug) $273.78
- Repatha (Biological) $257.99
- XARELTO (Drug) $204.20
- NEXLIZET (Drug) $190.53
- EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) $155.10
- Impella (Device) $145.00
- Corlanor (Drug) $139.90
- VERQUVO (Drug) $136.89
- 2ND GEN CENTRIMAG PRIMARY CONSOLE (Device) $133.21
- PRALUENT ALIROCUMAB INJECTION (Biological) $129.57
- LifeVest (Device) $119.19
- CAMZYOS (Drug) $110.31
- BRILINTA (Drug) $105.54
- JARDIANCE (Drug) $93.46
- Fortify Assura, Ellipse ICD (Device) $92.14
- CardioMEMS HF System (Device) $88.61
- VENASEAL (Device) $85.92
- Quadra Assura CRT Defibrillator (Device) $82.69
- MITRACLIP (Device) $82.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Redding
B Chandramouli, Md, MD
Cardiovascular Disease — Payments: $36,861
Cardiovascular Disease $36,861
Ms. Gisela Okonski, M.d, M.D
Cardiovascular Disease — Payments: $24,890
Cardiovascular Disease $24,890
Robert Pick, D.o, D.O
Cardiovascular Disease — Payments: $17,126
Cardiovascular Disease $17,126
Nikita Gill, M.d, M.D
Cardiovascular Disease — Payments: $15,368
Cardiovascular Disease $15,368
Thomas Russ, M.d, M.D
Cardiovascular Disease — Payments: $7,908
Cardiovascular Disease $7,908
Walter Fletscher, M.d, M.D
Cardiovascular Disease — Payments: $5,019
Cardiovascular Disease $5,019